You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Albuterol Sulfate And Ipratropium Bromide, and when can generic versions of Albuterol Sulfate And Ipratropium Bromide launch?

Albuterol Sulfate And Ipratropium Bromide is a drug marketed by Aiping Pharm Inc, Apotex Inc, Cipla, Luoxin Aurovitas, Nephron, Ritedose Corp, Sun Pharm, Teva Pharms, and Watson Labs Teva. and is included in nine NDAs.

The generic ingredient in ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE is albuterol sulfate; ipratropium bromide. There are thirty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Albuterol Sulfate And Ipratropium Bromide

A generic version of ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE was approved as albuterol sulfate; ipratropium bromide by CIPLA on December 31st, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE?
  • What are the global sales for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE?
  • What is Average Wholesale Price for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE?
Summary for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Drug patent expirations by year for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
Recent Clinical Trials for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
James J. Peters Veterans Affairs Medical CenterPhase 2
University of Texas Southwestern Medical CenterPhase 4
DeyPhase 3

See all ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE clinical trials

Pharmacology for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

US Patents and Regulatory Information for ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aiping Pharm Inc ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 076867-001 Dec 21, 2006 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 207875-001 Aug 7, 2017 AN RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Luoxin Aurovitas ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 206532-001 Jul 8, 2020 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 076724-001 Dec 31, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex Inc ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 077117-001 Dec 31, 2007 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.